Johnson & Johnson vs Natera, Inc. — Stock Comparison

JNJ
Johnson & Johnson
$227.19
▼ 1.16%
vs
NTRA
Natera, Inc.
$207.28
▲ 0.54%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 6/10

Q·Score Breakdown

7.1
Bullish
Overall
6
Neutral
9.3
Quality
2.5
6.5
Health
8.7
5.1
Growth
6.8
7.3
Valuation
5
6.5
Sentiment
8.2
JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

NTRA

Clean balance sheet with low leverage (0.1× debt-to-equity).

currently unprofitable (-9% margin).

Analyst Consensus

BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $258.00 (+24.5%)
18 analysts

Fundamentals

JNJ
NTRA
26.3×
Trailing P/E
17.9×
Forward P/E
-305.6×
21.8%
Profit Margin
-9.0%
68.0%
Gross Margin
64.7%
26.4%
ROE
-14.3%
9.9%
Revenue Growth
39.8%
-52.9%
Earnings Growth
0.33
Beta
1.68
Price / Book
$546.9B
Market Cap
$29.6B
$146 – $252
52-Week Range
$132 – $256

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →